Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

被引:352
作者
Nicholson, KG [1 ]
Colegate, AE
Podda, A
Stephenson, I
Wood, J
Ypma, E
Zambon, MC
机构
[1] Leicester Royal Infirm, Infect Dis Unit, Leicester LE1 5WW, Leics, England
[2] Chiron Vaccines, Siena, Italy
[3] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England
[4] Publ Hlth Lab Serv, London NW9 5EQ, England
关键词
D O I
10.1016/S0140-6736(00)05066-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background In 1997, pathogenic avian influenza A/Hong Kong/97 (H5N1) viruses emerged as a pandemic threat tc human beings, A non-pathogenic variant, influenza A/Duck/Singapore/97 (H5N3), was identified as a leading vaccine candidate. We did an observer-blind, phase I, randomised trial in healthy volunteers to assess safety, tolerability, and antigenicity of MF59-adjuvanted and non-adjuvanted vaccines. Methods 32 participants were randomly assigned MF59, and 33 non-adjuvanted vaccine. Two doses were given 3 weeks apart, of 7.5, 15, or 30 mug haemagglutinin surface-antigen influenza A H5N3 vaccine. Antibody responses were measured by haemagglutination inhibition, microneutralisation, and single radial haemolysis (SRH). The primary outcome was geometric mean antibody titre 21 days after vaccination. Findings The A/Duck/Singapore vaccines were safe and well tolerated. Antibody response to non-adjuvanted vaccine was poor, the best response occurring after two 30 mug doses: one, four, four, and one person of eleven seroconverted by haemagglutination inhibition, microneutralisation, H5N3 SRH, and H5N1 SRH, respectively. The geometric mean titres of antibody, and seroconversion rates, were significantly higher after MF59 adjuvanted vaccine. Two 7.5 mug doses of MF59 adjuvanted vaccine gave the highest seroconversion rates: haemagglutination inhibition, six of ten; microneutralisation, eight of ten; H5N3 SRH, ten of ten; H5N1 SRH, nine of ten. Geometric mean titre of antibody to the pathogenic virus, A/Hong Kong/489/97 (H5N1), was about half that to A/Duck/Singapore virus. Interpretation Non-adjuvanted A/Duck/Singapore/97 (H5N3) vaccines are poorly immunogenic and doses of 7.5-30 mug haemagglutinin alone are unlikely to give protection from A/Hong Kong/97 (H5N1) virus. Addition of MF59 to A/Duck/Singapore/97 vaccines boost the antibody response to protection levels. Our findings have implications for development and assessment of vaccines for future pandemics.
引用
收藏
页码:1937 / 1943
页数:7
相关论文
共 29 条
  • [1] INTERPRETATION OF RESPONSES AND PROTECTIVE LEVELS OF ANTIBODY AGAINST ATTENUATED INFLUENZA-A VIRUSES USING SINGLE RADIAL HEMOLYSIS
    ALKHAYATT, R
    JENNINGS, R
    POTTER, CW
    [J]. JOURNAL OF HYGIENE, 1984, 93 (02): : 301 - 312
  • [2] CHARACTERIZATION OF VIRULENT AND AVIRULENT A-CHICKEN-PENNSYLVANIA-83 INFLUENZA-A VIRUSES - POTENTIAL ROLE OF DEFECTIVE INTERFERING RNAS IN NATURE
    BEAN, WJ
    KAWAOKA, Y
    WOOD, JM
    PEARSON, JE
    WEBSTER, RG
    [J]. JOURNAL OF VIROLOGY, 1985, 54 (01) : 151 - 160
  • [3] REPLICATION OF AVIAN INFLUENZA-VIRUSES IN HUMANS
    BEARE, AS
    WEBSTER, RG
    [J]. ARCHIVES OF VIROLOGY, 1991, 119 (1-2) : 37 - 42
  • [4] Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong
    Bridges, CB
    Katz, JM
    Seto, WH
    Chan, PKS
    Tsang, D
    Ho, W
    Mak, KH
    Lim, W
    Tam, JS
    Clarke, M
    Williams, SG
    Mounts, AW
    Bresee, JS
    Conn, LA
    Rowe, T
    Hu-Primmer, J
    Abernathy, RA
    Lu, XH
    Cox, NJ
    Fukuda, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) : 344 - 348
  • [5] Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus
    Claas, ECJ
    Osterhaus, ADME
    van Beek, R
    De Jong, JC
    Rimmelzwaan, GF
    Senne, DA
    Krauss, S
    Shortridge, KF
    Webster, RG
    [J]. LANCET, 1998, 351 (9101) : 472 - 477
  • [6] Delem A, 1977, Dev Biol Stand, V39, P391
  • [7] ELLIS J, 1997, EUR J EPIDEMIOL, V13, P1
  • [8] *EUR COMM PROPR ME, 1996, CPMPBWP21496
  • [9] REPLICATION OF AVIAN INFLUENZA-A VIRUSES IN MAMMALS
    HINSHAW, VS
    WEBSTER, RG
    EASTERDAY, BC
    BEAN, WJ
    [J]. INFECTION AND IMMUNITY, 1981, 34 (02) : 354 - 361
  • [10] Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts
    Katz, JM
    Lim, W
    Bridges, CB
    Rowe, T
    Hu-Primmer, J
    Lu, XH
    Abernathy, RA
    Clarke, M
    Conn, L
    Kwong, H
    Lee, M
    Au, G
    Ho, YY
    Mak, KH
    Cox, NJ
    Fukuda, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) : 1763 - 1770